Introducing Twelve Converter! Real-time currency rates at your fingertips. Available on Android, iOS soon!

SRPT

43.0099983 USD
3.8
9.69%
Last update Jun 6, 3:59 PM EDT
Pre-market
Day range
40.45000
43.54000
Previous close
39.21000
Open
40.45000
Access this stock data via API
Subscribe
Sarepta Therapeutics Inc.
43.01
3.80
9.69%

Overview

Description

Sarepta Therapeutics Inc. is a biopharmaceutical company dedicated to developing precision genetic medicine for the treatment of rare neuromuscular diseases. With an emphasis on RNA-targeted therapeutics, Sarepta's primary focus is on Duchenne muscular dystrophy (DMD), a severe and progressive muscle degeneration disorder. The company's pipeline features innovative gene therapy and RNA-based technologies designed to address the underlying genetic cause of DMD, offering potential to alter the disease trajectory. Sarepta Therapeutics engages primarily with the healthcare and life sciences industries, collaborating with academic institutions and leveraging advanced bioinformatics tools for drug discovery and development. Situated at the forefront of genetic medicine, Sarepta plays a significant role in pioneering treatments that could revolutionize care for rare diseases, making substantial impacts on both patients' lives and the broader biopharmaceutical landscape.

About

CEO
Mr. Douglas S. Ingram Esq.
Employees
1372
Address
215 First Street
Suite 415
Cambridge, 02142, MA
United States
Phone
617 274 4000
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Pre-market

Exchange is currently open for pre-market.
Main market opens in 1 day 4 hours 57 minutes

04:32
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).